Advanced search
Publication Cover
Acta Oncologica Volume 58, 2019 - Issue 6
Journal homepage
1,619
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: MEDICAL ONCOLOGY

The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study

Louise Skau RasmussenDepartment of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; ;Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Aalborg, Denmark; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6042-779XView further author information
ORCID Icon,
Benny VittrupDepartment of Oncology, University Hospital Herlev, Herlev, Denmark; View further author information
,
Morten LadekarlDepartment of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; ;Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Aalborg, Denmark; ;Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; View further author information
,
Per PfeifferDepartment of Oncology, Odense University Hospital, Odense, Denmark; View further author information
,
Mette Karen YilmazDepartment of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; View further author information
,
Laurids Østergaard PoulsenDepartment of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; ;Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Aalborg, Denmark; View further author information
,
Kell ØsterlindDepartment of Oncology, North Sealand Hospital, Hillerød, Denmark; View further author information
,
Carsten Palnæs HansenDepartment of Surgical Gastroenterology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; View further author information
,
Michael Bau MortensenOdense Pancreas Center (OPAC), Department of Surgery, Odense University Hospital, Odense, Denmark; View further author information
,
Frank Viborg MortensenDepartment of Surgical Gastroenterology, Aarhus University Hospital, Aarhus, Denmark; View further author information
,
Mogens SallDepartment of Surgical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark; View further author information
,
Sönke DetlefsenOdense Pancreas Center (OPAC), Department of Pathology, Odense University Hospital, Odense, Denmark; ORCID Iconhttp://orcid.org/0000-0002-9466-2333View further author information
ORCID Icon,
Martin BøgstedDepartment of Haematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; ;Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Aalborg, Denmark; View further author information
&
Claus Wilki FristrupDanish Pancreatic Cancer Database, Denmark; ;Department of Surgery, Odense University Hospital, Odense, DenmarkView further author information
 show all
Pages 864-871 | Received 29 Oct 2018, Accepted 06 Feb 2019, Published online: 25 Mar 2019

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Charles Vesteghem, Rasmus Froberg Brøndum, Ursula G Falkmer, Anton Pottegård, Laurids Østergaard Poulsen & Martin Bøgsted. (2021) High Validity of the Danish National Patient Registry for Systemic Anticancer Treatment Registration from 2009 to 2019. Clinical Epidemiology 13, pages 1085-1094.
Read now

Articles from other publishers (14)

Jakob Kirkegård, Morten Ladekarl, Andrea Lund & Frank Mortensen. (2023) Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial Emulation. Annals of Surgical Oncology 31:2, pages 1310-1318.
Crossref
Trine Aaquist, Claus W. Fristrup, Jane P. Hasselby, Stephen Hamilton-Dutoit, Mikkel Eld, Per Pfeiffer, Michael B. Mortensen & Sönke Detlefsen. (2024) Prognostic value of margin clearance in total and distal pancreatectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study. Pathology - Research and Practice, pages 155077.
Crossref
Nitin Sudhakar Shetty, Ujjwal Agarwal, Amit Choudhari, Anurag Gupta, Nandakumar PG, Manish Bhandare, Kunal Gala, Daksh Chandra, Anant Ramaswamy, Vikas Ostwal, Shailesh V. Shrikhande & Suyash S. Kulkarni. (2023) Imaging Recommendations for Diagnosis, Staging, and Management of Pancreatic Cancer. Indian Journal of Medical and Paediatric Oncology 44:01, pages 077-083.
Crossref
Ambrose Okem, Charlotte Henstra, Maarten Lambert & Rose Hayeshi. (2023) A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment. Medicine in Drug Discovery 17, pages 100147.
Crossref
Leila Vahedi, Touraj Asvadi Kermani, Mohammad Asghari-Jafarabadi, Elham Asghari, SeyedehMomeneh Mohammadi & Amin Khameneh. (2023) Survival and prognostic factors among hospitalized pancreatic cancer patients in northwestern Iran. Journal of Research in Medical Sciences 28:1, pages 4.
Crossref
C. Vesteghem, R.F. Brøndum, M.T. Mouritzen, H.S. Christensen, M. Bøgsted, U.G. Falkmer & L.Ø. Poulsen. (2022) Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019. Clinical Oncology 34:8, pages 487-496.
Crossref
Susann Theile, Julia Sidenius Johansen, Dorte Lisbet Nielsen, Benny Vittrup Jensen, Carsten Palnæs Hansen, Jane Preuss Hasselby, Sverrir Vídalín Eiríksson & Inna Markovna Chen. (2022) A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC). Pharmaceutics 14:3, pages 509.
Crossref
Yang Yang, Zi-Jian Zhang, Yu Wen, Li Xiong, Yun-Peng Huang, Yong-Xiang Wang & Kai Liu. (2021) Novel perspective in pancreatic cancer therapy: Targeting ferroptosis pathway. World Journal of Gastrointestinal Oncology 13:11, pages 1668-1679.
Crossref
Annalisa Pappalardo, Emilio Francesco Giunta, Giuseppe Tirino, Luca Pompella, Piera Federico, Bruno Daniele, Ferdinando De Vita & Angelica Petrillo. (2021) Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting. Frontiers in Oncology 11.
Crossref
Huazhong Cai, Yanxia Chen, Liusheng Xu, Yingping Zou, Xiaoliang Zhou, Guoxin Liang, Dongqing Wang & Zhimin Tao. (2021) Differently PEGylated Polymer Nanoparticles for Pancreatic Cancer Delivery: Using a Novel Near-Infrared Emissive and Biodegradable Polymer as the Fluorescence Tracer. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Sidsel C. Lindgaard, Zsófia Sztupinszki, Emil Maag, Inna M. Chen, Astrid Z. Johansen, Benny V. Jensen, Stig E. Bojesen, Dorte L. Nielsen, Carsten P. Hansen, Jane P. Hasselby, Kaspar R. Nielsen, Zoltan Szallasi & Julia S. Johansen. (2021) Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification. Clinical Cancer Research 27:9, pages 2592-2603.
Crossref
Anthony Turpin, Mehdi el Amrani, Jean-Baptiste Bachet, Daniel Pietrasz, Lilian Schwarz & Pascal Hammel. (2020) Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021. Cancers 12:12, pages 3866.
Crossref
Stijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, Quisette P. Janssen, Mohammed Abu Hilal, Adnan Alseidi, Alberto Balduzzi, Gianpaolo Balzano, Claudio Bassi, Frederik Berrevoet, Morgan Bonds, Olivier R. Busch, Giovanni Butturini, Marco del Chiaro, Kevin C. Conlon, Massimo Falconi, Isabella Frigerio, Giuseppe K. Fusai, Johan Gagnière, Oonagh Griffin, Thilo Hackert, Asif Halimi, Ulla Klaiber, Knut J. Labori, Giuseppe Malleo, Marco V. Marino, Michael B. Mortensen, Andrej Nikov, Mickaël Lesurtel, Tobias Keck, Jörg Kleeff, Rupaly Pandé, Per Pfeiffer, D. Pietrasz, Keith J. Roberts, Antonio Sa Cunha, Roberto Salvia, Oliver Strobel, Timo Tarvainen, Patrick M. Bossuyt, Hanneke W. M. van Laarhoven, Johanna W. Wilmink, Bas Groot Koerkamp & Marc G. Besselink. (2020) Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. JAMA Oncology 6:11, pages 1733.
Crossref
Louise S. Rasmussen, Claus W. Fristrup, Benny V. Jensen, Per Pfeiffer, Britta Weber, Mette K. Yilmaz, Laurids Ø. Poulsen, Morten Ladekarl, Kell Østerlind, Jim S. Larsen, Hella Skuladottir, Carsten P. Hansen, Michael B. Mortensen, Frank V. Mortensen, Mogens Sall, Sönke Detlefsen, Martin Bøgsted & Ursula G. Falkmer. (2020) Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study. European Journal of Cancer 129, pages 50-59.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.